NCT06044493View on ClinicalTrials.gov

MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients

PHASE4RecruitingINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

November 30, 2025

Conditions
Kidney Transplant
Interventions
DRUG

Myreptic-N Tablet

Up to 720mg BID(total 1440mg daily), PO - Check the blood concentration of Mycophenolate at each visit

DRUG

Mycophenolate mofetil Tablet/Capsule

Up to 1g BID(total 2g daily), PO - Check the blood concentration of Mycophenolate at each visit

Trial Locations (1)

03080

RECRUITING

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY